Posting of Circular

9th Dec 2009 08:04

9 December 2009 Verona Pharma plc ("Verona" or the "Company") (AIM: VRP.L) POSTING OF CIRCULAR

The Company announces that further to the announcement of its GBP3 million fundraising (before expenses) made on 8 December 2009, a circular convening a General Meeting of shareholders (the 'Circular') has now been posted to shareholders. The purpose of the General Meeting is to seek the relevant approvals in respect of the issue of the New Ordinary Shares.

The funds will be used to develop further the Company's lead drug, RPL554, as well as its two other drug development projects: Cough and NAIPs, whilst the Company pursues licensing partnership opportunities for RPL554.

The Circular is also available to view on the Company's website www.veronapharma.com --END-- Enquiries

For more information please contact:

Professor Clive Page 020 7863 3300 Chairman, Verona Pharma plc

Barry Saint / Tim Redfern / Esther Lee 020 7071 4300 Evolution Securities Limited Suzanne Johnson-Walsh / Gemma O'Hara 020 7562 3350

Bishopsgate Communications UKMAT:12000878.3 1 1 UKMAT:12000878.3

vendor

---

Related Shares:

VRP.L